Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure

被引:39
|
作者
Froehlich, Georg M. [1 ,2 ]
Keller, Philipp [1 ]
Schmid, Florian [1 ]
Wolfrum, Mathias [1 ]
Osranek, Martin [1 ]
Falk, Christian [1 ]
Noll, Georg [1 ]
Enseleit, Frank [1 ]
Reinthaler, Markus [2 ]
Meier, Pascal [2 ]
Luescher, Thomas F. [1 ]
Ruschitzka, Frank [1 ]
Tanner, Felix C. [1 ]
机构
[1] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland
[2] Univ Coll London Hosp, Heart Hosp, London, England
基金
瑞士国家科学基金会;
关键词
Pericardial effusion; Heart failure; Mortality; SYSTEMIC INFLAMMATION; EUROPEAN ASSOCIATION; PLEURAL EFFUSIONS; PULMONARY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; GUIDELINES; MANAGEMENT; CARDIOLOGY; PROGNOSIS;
D O I
10.1093/eurheartj/eht006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pericardial effusion (PE) is a common finding in cardiac patients with chronic heart failure. The prognostic relevance of a small, haemodynamically non-compromising PE in such patients, however, remains to be determined. All patients referred to our heart failure clinic and having a baseline echocardiography and follow-up clinical visits were included. Patients with a haemodynamically relevant PE, acute myo-/pericarditis, systemic sclerosis, rheumatoid arthritis, heart transplantation, heart surgery within the last 6 months or malignancies within the last 3 years were excluded. Patients with or without a haemodynamically irrelevant PE were compared regarding all-cause mortality as the primary and cardiovascular death or need for heart transplantation as secondary outcomes. A total of 897 patients (824 patients in the control vs. 73 patients in the PE group) were included. In the PE group, left ventricular ejection fraction (LVEF) was lower [31, interquartile range (IQR): 18.045.0] than in controls (34, IQR: 25.047.0; P 0.04), while the end-systolic diameters of the left ventricle and the left atrium were larger (P 0.01 and P 0.001, respectively). Similarly, in patients with PE, the right ventricle (RV) systolic function was lower (P 0.005 for both the fractional area change and the tricuspid annulus movement), the dimensions of RV and right atrium (RA) were larger (P 0.05 for RV and P 0.01 for RA), and the degree of tricuspid regurgitation was higher (P 0.0001). Furthermore, in the PE group, the heart rate was higher (P 0.001) and the leukocyte count as well as CRP values were increased (P 0.004 and P 0.0001, respectively); beta-blocker use was less frequent (P 0.04), while spironolactone use was more frequent (P 0.03). The overall survival was reduced in the PE group compared with controls (P 0.02). Patients with PE were more likely to suffer cardiovascular death (1-year estimated event-free survival: 86 5 vs. 95 1; P 0.01) and to require heart transplantation (1-year estimated event-free survival: 88 4 vs. 95 1; P 0.009). A multivariate Cox proportional hazard model revealed the following independent predictors of mortality: (a) PE (P 0.04, hazard ratio (HR): 1.95, 95 confidence interval (CI): 1.03.7), (b) age (P 0.04, HR: 1.02, 95 CI: 1.01.04) and (c) LVEF 35 (P 0.03, HR: 1.7, 95 CI: 1.12.8). In chronic heart failure, even minor PEs are associated with an increased risk of all-cause mortality, cardiac death, and need for transplantation.
引用
收藏
页码:1414 / 1423
页数:10
相关论文
共 50 条
  • [1] Small hemodynamically non-compromising pericardial effusion is associated with increased mortality in patients with heart failure
    Keller, P.
    Froehlich, G. M.
    Schmid, F.
    Enseleit, F.
    Luescher, T. F.
    Noll, G.
    Ruschitzka, F. T.
    Tanner, F. C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 173 - 173
  • [2] Prognosis investigation in patients with chronic heart failure and pericardial effusion
    Yu Sheng-bo
    Zhao Qing-yan
    Huang He
    Chen Dong-e
    Cui Hong-ying
    Qin Mu
    Huang Cong-xin
    CHINESE MEDICAL JOURNAL, 2012, 125 (05) : 882 - 887
  • [3] The Prognosis Investigation in Patients with Chronic Heart Failure and Pericardial Effusion
    Yu, Shengbo
    Zhao, Qingyan
    Huang, He
    Cui, Hongying
    Qin, Mu
    Huang, Congxin
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S58 - S58
  • [4] Prognosis investigation in patients with chronic heart failure and pericardial effusion
    YU ShengboZHAO QingyanHUANG HeCHEN DongeCUI HongyingQIN Mu and HUANG Congxin Cardiovascular Research Institute of Wuhan UniversityRenmin Hospital of Wuhan UniversityWuhanHubei China Department of StatisticsInstitute of Public HealthWuhan UniversityWuhanHubei China
    中华医学杂志(英文版), 2012, (05) : 882 - 887
  • [5] THE PROGNOSIS INVESTIGATION IN PATIENTS WITH CHRONIC HEART FAILURE AND PERICARDIAL EFFUSION
    Yu Shengbo
    Zhao Qingyan
    Huang He
    Chen Donge
    Cui Hongying
    Huang Congxin
    HEART, 2010, 96 : A186 - A186
  • [6] REFRACTORY CHRONIC CONGESTIVE HEART FAILURE AND PERICARDIAL EFFUSION
    WESSELY, Z
    RAIA, FE
    NEW YORK STATE JOURNAL OF MEDICINE, 1971, 71 (10) : 1100 - +
  • [7] Pericardial effusion and heart failure
    Aksu, Ugur
    Kalkan, Kamuran
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 192 : 21 - 21
  • [8] Pericardial effusion is a marker of increased mortality in thalassemia major patients
    Meloni, A.
    Toia, P.
    Neri, M. G.
    Renne, S.
    Valeri, G.
    Positano, V.
    Renni, R.
    Mattei, R.
    Salvatori, C.
    Pepe, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1173 - 1173
  • [9] Pericardial Effusion Is a Marker of Increased Mortality in Thalassemia Major Patients
    Meloni, Antonella
    Toia, Patrizia
    Sardella, Leonardo
    Serra, Giuseppe
    Chiari, Roberta
    D'Ambrosio, Alfonso
    De Franceschi, Lucia
    Neri, Maria Giovanna
    Resta, Maria Chiara
    Preziosi, Paolo
    Positano, Vincenzo
    Benni, Monica
    Pepe, Alessia
    BLOOD, 2014, 124 (21)
  • [10] PERICARDIAL EFFUSION IN CONGESTIVE HEART FAILURE
    WINTERS, WL
    CARTER, BL
    STAUFFER, HM
    SOLOFF, LA
    DISEASES OF THE CHEST, 1961, 40 (01): : 82 - 86